GXID Stock Overview
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Gerresheimer AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €100.15 |
| 52 Week High | €119.10 |
| 52 Week Low | €84.00 |
| Beta | 0.90 |
| 1 Month Change | -3.14% |
| 3 Month Change | 13.26% |
| 1 Year Change | 15.65% |
| 3 Year Change | 12.59% |
| 5 Year Change | 50.26% |
| Change since IPO | 187.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| GXID | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | -3.2% | -8.6% | -0.9% |
| 1Y | 15.6% | -45.7% | -1.8% |
Return vs Industry: GXID exceeded the UK Life Sciences industry which returned -45.4% over the past year.
Return vs Market: GXID exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| GXID volatility | |
|---|---|
| GXID Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GXID has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GXID's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1864 | 11,947 | Dietmar Siemssen | www.gerresheimer.com |
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Gerresheimer AG Fundamentals Summary
| GXID fundamental statistics | |
|---|---|
| Market cap | €3.42b |
| Earnings (TTM) | €117.09m |
| Revenue (TTM) | €2.00b |
29.2x
P/E Ratio1.7x
P/S RatioIs GXID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GXID income statement (TTM) | |
|---|---|
| Revenue | €2.00b |
| Cost of Revenue | €1.41b |
| Gross Profit | €592.85m |
| Other Expenses | €475.77m |
| Earnings | €117.09m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
Jul 11, 2024
| Earnings per share (EPS) | 3.39 |
| Gross Margin | 29.66% |
| Net Profit Margin | 5.86% |
| Debt/Equity Ratio | 76.4% |
How did GXID perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield36%
Payout RatioDoes GXID pay a reliable dividends?
See GXID dividend history and benchmarks| Gerresheimer dividend dates | |
|---|---|
| Ex Dividend Date | Jun 06 2024 |
| Dividend Pay Date | Jun 10 2024 |
| Days until Ex dividend | 44 days |
| Days until Dividend pay date | 48 days |
Does GXID pay a reliable dividends?
See GXID dividend history and benchmarks